Gout: An old disease in new perspective - A review

被引:341
作者
Ragab, Gaafar [1 ]
Elshahaly, Mohsen [2 ]
Bardin, Thomas [3 ,4 ]
机构
[1] Cairo Univ, Fac Med, Dept Internal Med, Rheumatol & Clin Immunol Unit, Cairo, Egypt
[2] Suez Canal Univ, Rheumatol, Phys Med & Rehabil, Fac Med, Ismailia, Egypt
[3] Lariboisiere Hosp, Rhumatol, Paris, France
[4] Univ Paris Diderot, Sorbonne Cite, Paris, France
关键词
Hyperuricemia; Gout; Pathogenesis; Clinical picture of gout; Imaging modalities; Management of gout; DUAL-ENERGY CT; CUTANEOUS ADVERSE-REACTIONS; SERUM URIC-ACID; EVIDENCE-BASED RECOMMENDATIONS; OF-RHEUMATOLOGY GUIDELINES; URATE CRYSTAL DEPOSITION; DOUBLE-BLIND; TOPHACEOUS GOUT; COMPUTED-TOMOGRAPHY; AMERICAN-COLLEGE;
D O I
10.1016/j.jare.2017.04.008
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Gout is a picturesque presentation of uric acid disturbance. It is the most well understood and described type of arthritis. Its epidemiology is studied. New insights into the pathophysiology of hyperuricemia and gouty arthritis; acute and chronic allow for an even better understanding of the disease. The role of genetic predisposition is becoming more evident. The clinical picture of gout is divided into asymptomatic hyperuricemia, acute gouty arthritis, intercritical period, and chronic tophaceous gout. Diagnosis is based on laboratory and radiological features. The gold standard of diagnosis is identification of characteristic MSU crystals in the synovial fluid using polarized light microscopy. Imaging modalities include conventional radiography, ultrasonography, conventional CT, Dual-Energy CT, Magnetic Resonance Imaging, nuclear scintigraphy, and positron emission tomography. There is remarkable progress in the application of ultrasonography and Dual-Energy CT which is bound to influence the diagnosis, staging, follow-up, and clinical research in the field. Management of gout includes management of flares, chronic gout and prevention of flares, as well as management of comorbidities. Newer drugs in the pharmacological armamentarium are proving successful and supplement older ones. Other important points in its management include patient education, diet and life style changes, as well as cessation of hyperuricemic drugs. (C) 2017 Production and hosting by Elsevier B.V. on behalf of Cairo University. This is an open access article under the CC BY-NC-ND license
引用
收藏
页码:495 / 511
页数:17
相关论文
共 50 条
  • [41] Efficacy and Safety of Lesinurad in Patients with Hyperuricemia Associated with Gout: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Wu, Jie-Ying
    Chang, Ya-Ting
    Lin, Ying-Chin
    Lee, Chia-Hwa
    Loh, El-Wui
    Wu, Mei-Yi
    Chang, Yu-Sheng
    Tam, Ka-Wai
    PHARMACOTHERAPY, 2018, 38 (11): : 1106 - 1119
  • [42] Imaging as a potential outcome measure in gout studies: A systematic literature review
    Durcan, Laura
    Grainger, Rebecca
    Keen, Helen I.
    Taylor, William J.
    Dalbeth, Nicola
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2016, 45 (05) : 570 - 579
  • [43] Gout and Hyperuricemia: an Historical Perspective
    C. Ronald MacKenzie
    Current Treatment Options in Rheumatology, 2015, 1 (2) : 119 - 130
  • [44] Narrative Review: Peripheral Arterial Disease in Patients with Hyperuricemia and Gout
    Nicole Leung
    Charles Fang
    Jay Pendse
    Michael Toprover
    Michael H. Pillinger
    Current Rheumatology Reports, 2023, 25 : 83 - 97
  • [45] Hyperuricemia, Gout, and Cardiovascular Disease: An Update
    Abeles, Aryeh M.
    CURRENT RHEUMATOLOGY REPORTS, 2015, 17 (03)
  • [46] Weight loss for overweight and obese individuals with gout: a systematic review of longitudinal studies
    Nielsen, Sabrina M.
    Bartels, Else M.
    Henriksen, Marius
    Waehrens, Eva E.
    Gudbergsen, Henrik
    Bliddal, Henning
    Astrup, Arne
    Knop, Filip K.
    Carmona, Loreto
    Taylor, William J.
    Singh, Jasvinder A.
    Perez-Ruiz, Fernando
    Kristensen, Lars E.
    Christensen, Robin
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 (11) : 1870 - 1882
  • [47] Efficacy and safety of gout flare prophylaxis and therapy use in people with chronic kidney disease: a Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN)-initiated literature review
    Pisaniello, Huai Leng
    Fisher, Mark C.
    Farquhar, Hamish
    Vargas-Santos, Ana Beatriz
    Hill, Catherine L.
    Stamp, Lisa K.
    Gaffo, Angelo L.
    ARTHRITIS RESEARCH & THERAPY, 2021, 23 (01)
  • [48] Budget impact of adding lesinurad for second-line treatment of gout: a US health plan perspective
    Klein, Robert W.
    Kabadi, Shaum
    Cinfio, Frank N.
    Bly, Christopher A.
    Taylor, Douglas C. A.
    Szymanski, Keith A.
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2018, 7 (08) : 807 - 816
  • [49] Gout, Hyperuricemia, and Ear Function: A Systematic Review
    Skare, Thelma L.
    de Carvalho, Jozelio Freire
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2024, 26 (05): : 318 - 323
  • [50] The current state of care in gout: Addressing the need for better understanding of an ancient disease
    Zychowicz, Michael E.
    Pope, Richard S.
    Graser, Elke
    JOURNAL OF THE AMERICAN ACADEMY OF NURSE PRACTITIONERS, 2010, 22 : 623 - 636